LYFE Sciences · Project HERA
Variant Interpretation · Classification Report
Variant classification summary
NM_001127510.3:c.3479C>A
APC
· NP_001120982.1:p.(Thr1160Lys)
· NM_001127510.3
GRCh37: chr5:112174770 C>A
·
GRCh38: chr5:112839073 C>A
Gene:
APC
Transcript:
NM_001127510.3
Final call
Likely Benign
BS1 strong
BP1 supporting
Variant details
Gene
APC
Transcript
NM_001127510.3
Protein
NP_001120982.1:p.(Thr1160Lys)
gnomAD AF
0.0002695250782242325 (v4.1)
ClinVar
Likely benign
OncoKB
Unknown Oncogenic Effect
Classification rationale
Interpretation summary
Generated evidence synthesis
1
BS1 (Strong): population allele frequency 0.048% in gnomAD v4.1 exceeds the >=0.001% benign threshold by ~48-fold in both gnomAD releases.
2
BP1 (Supporting): missense change outside the VCEP's excepted beta-catenin repeat (codons 1021-1035) is consistent with benign supporting evidence.
3
Overall: Likely Benign — BS1 (Strong) + BP1 (Supporting), no pathogenic criteria met (APC VCEP v2.1).
Final determination:
Rule26: exactly one of BS1/BS2/BS3/BS4 met (Benign.Strong) → Likely Benign.
Criteria assessment
ACMG/AMP criteria review
Criteria shown when status is available
All criteria require review: For research and educational purposes only.
| Criterion | Status | Rationale | Evidence used |
|---|---|---|---|
| PVS1 | N/A | Not applicable: p.(Thr1160Lys) is a missense substitution, and PVS1 is reserved for null variants (nonsense, frameshift, splice-site, or deletion). |
cspec
|
| PS1 | Not met | Not met: no established Pathogenic or Likely Pathogenic APC missense produces p.Thr1160Lys; only codons 1026 and 1028 qualify. |
cspec
|
| PS2 | Not assessed | Not assessed: no de novo observation with both parents tested was available for this variant. |
cspec
|
| PS3 | Not assessed | Not assessed: no functional assay data (protein or RNA) for this specific variant was available. |
|
| PS4 | Not assessed | Not assessed: insufficient individual-level phenotype detail was available to assign phenotype points. |
cspec
vcep_table_1_262
PMID:18199528
|
| PM1 | N/A | Not applicable: the APC VCEP designates PM1 (mutational hotspot) as not applicable for this gene. |
cspec
|
| PM2 | Not met | Not met: gnomAD v4.1 allele frequency 0.02695% (435 alleles) far exceeds the <=0.0003% PM2 threshold. |
cspec
gnomad_v2
gnomad_v4
|
| PM3 | N/A | Not applicable: PM3 is not used under the APC VCEP because familial adenomatous polyposis is autosomal dominant. |
cspec
|
| PM4 | N/A | Not applicable: p.Thr1160Lys is a missense substitution with no protein-length change, and the VCEP does not use PM4. |
cspec
vcep_table_1_262
|
| PM5 | Not met | Not met: no established Pathogenic or Likely Pathogenic missense variant at codon 1160; only codons 1026 and 1028 qualify. |
cspec
pm5_candidates
|
| PM6 | Not assessed | Not assessed: no observation of this variant as de novo with parental relationships unconfirmed was available. |
cspec
|
| PP1 | Not assessed | Not assessed: no pedigree or affected-relative data were available to establish co-segregation. |
cspec
|
| PP2 | N/A | Not applicable: the APC VCEP marks PP2 as not applicable because missense variants are not a frequent APC disease mechanism. |
cspec
|
| PP3 | Not met | Not met: SpliceAI predicts no splice impact (all four delta scores 0.00, below the 0.2 threshold). |
cspec
spliceai
|
| PP4 | N/A | Not applicable: phenotype and family-history evidence is captured through the PS4 specifications per the APC VCEP. |
cspec
vcep_apc_specifications_supplementary_material_v2
|
| PP5 | N/A | Not applicable: PP5 is not used under the APC VCEP, and ClinVar has no expert-panel submission for this variant. |
cspec
vcep_apc_specifications_supplementary_material_v2
clinvar
|
| BA1 | Not met | Not met: highest observed population allele frequency 0.048% is below the >=0.1% BA1 threshold. |
cspec
gnomad_v4
|
| BS1 | Met | Met (Strong): highest observed population allele frequency 0.048% exceeds the >=0.001% BS1 threshold in both gnomAD releases. |
cspec
gnomad_v2
gnomad_v4
|
| BS2 | Not met | Not met: zero homozygotes and no healthy-individual observations meeting the VCEP requirements (>=10 points) were available. |
cspec
gnomad_v2
gnomad_v4
|
| BS3 | Not assessed | Not assessed: no protein functional assay data for this variant were available; the RNA-assay arm does not apply to missense changes. |
|
| BS4 | Not assessed | Not assessed: no affected relative tested negative for this variant, and no non-segregation phenotype data were available. |
cspec
|
| BP1 | Met | Met (Supporting): p.Thr1160Lys falls outside the excepted beta-catenin repeat (codons 1021-1035), where missense is generally benign in APC. |
cspec
|
| BP2 | Not assessed | Not assessed: no qualifying co-occurring pathogenic APC variant or phase information was available. |
cspec
|
| BP3 | N/A | Not applicable: the variant is a missense substitution, not an in-frame indel, and the VCEP does not use BP3. |
cspec
vcep_table_1_262
|
| BP4 | N/A | Not applicable: BP4 applies only to synonymous or intronic variants; c.3479C>A is a missense change. |
cspec
|
| BP5 | Not assessed | Not assessed: no evidence of an alternate molecular diagnosis in a p.Thr1160Lys carrier was available. |
cspec
PMID:18199528
|
| BP6 | N/A | Not applicable: BP6 is not used under the APC VCEP, and ClinVar has no expert-panel benign classification for this variant. |
cspec
clinvar
|
| BP7 | N/A | Not applicable: BP7 applies only to synonymous or intronic variants; this is a missense change. |
cspec
|
Disclaimer:
The content and results provided by LYFE Sciences are for research and educational purposes only and must not be used as a substitute for professional medical judgment, diagnosis, or treatment. Always consult a qualified healthcare professional before making any clinical decisions.